Clinical trial
ACB A Randomized Study of 2.5ug/kg/Day vs. 5ug/kg/Day Dose of G-CSF After High…
NCT00168168 · Alberta Health services, Other · Completed
Key facts
| NCT number | NCT00168168 |
|---|---|
| Title | ACB A Randomized Study of 2.5ug/kg/Day vs. 5ug/kg/Day Dose of G-CSF After High Dose Chemotherapy Followed by Autologous Peripheral Blood Stem Cell/Marrow Transplant Recipients FILE#17159 |
| Official title | ACB A Randomized Study of 2.5ug/kg/Day vs. 5ug/kg/Day Dose of G-CSF After High Dose Chemotherapy Followed by Autologous Peripheral Blood Stem Cell/Marrow Transplant Recipients FILE#17159 |
| Lead sponsor | Alberta Health services, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Peripheral Stem Cell/Marrow Transplant |
| Intervention type | Drug |
| Interventions | G-CSF/Filgrastim |
| Enrollment | 60 |
| Start date | Jul 1, 2003 |
| Completion | Feb 1, 2007 |
| First posted | Sep 15, 2005 |
| Last update posted | Feb 9, 2010 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: